Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription

Nucleic Acids Research

Volumn 40, Issue 4, 2012, Pages 1609-1620

  Li, Ping ^a   Zhao, Yuhao ^a   Wu, Xiaoyan ^b   Xia, Minjie ^a   Fang, Mingming ^a,c   Iwasaki, Yasumasa ^d   Sha, Jiahao ^a   Chen, Qi ^a   Xu, Yong ^a   Shen, Aiguo ^b  

^a Nanjing Medical University   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Jiankang Vocational Institute   (China)

^d KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYPERMETHYLATED IN CANCER 1 PROTEIN; RNA; SIRTUIN 1; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL METABOLISM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENERGY EXPENDITURE; GENE EXPRESSION; GENETIC TRANSFECTION; HOMEOSTASIS; MUSCLE CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CELL LINE; DOWN-REGULATION; ENERGY METABOLISM; HISTONES; HOMEOSTASIS; HUMANS; INTERFERON-GAMMA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUSCLE FIBERS, SKELETAL; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; SIRTUIN 1; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 84863230325     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr984     Document Type: Article

References (48)

1. Yechoor, V. K., Patti, M. E., Saccone, R. and Kahn, C. R. (2002) Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc. Natl Acad. Sci. USA, 99, 10587-10592.
2. Simoneau, J. A., Veerkamp, J. H., Turcotte, L. P. and Kelley, D. E. (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J., 13, 2051-2060. (Pubitemid 29517635)
3. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R. et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA, 100, 8466-8471. (Pubitemid 36842568)
4. Kelley, D. E., He, J., Menshikova, E. V. and Ritov, V. B. (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 51, 2944-2950.
5. Canto, C. and Auwerx, J. (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol., 20, 98-105.
6. Gross, D. N., van den Heuvel, A. P. and Birnbaum, M. J. (2008) The role of FoxO in the regulation of metabolism. Oncogene, 27, 2320-2336. (Pubitemid 351501783)
7. Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J. T., Depinho, R. A., Puigserver, P. and White, M. F. (2009) Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat. Med., 15, 1307-1311.
8. Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J. and Auwerx, J. (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell. Metab., 8, 347-358.
9. Kitamura, Y. I., Kitamura, T., Kruse, J. P., Raum, J. C., Stein, R., Gu, W. and Accili, D. (2005) FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell. Metab., 2, 153-163.
10. Frescas, D., Valenti, L. and Accili, D. (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem., 280, 20589-20595. (Pubitemid 40776761)
11. Banks, A. S., Kon, N., Knight, C., Matsumoto, M., Gutierrez-Juarez, R., Rossetti, L., Gu, W. and Accili, D. (2008) SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell. Metab., 8, 333-341.
12. Lin, S. J., Defossez, P. A. and Guarente, L. (2000) Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science, 289, 2126-2128.
13. Liang, F., Kume, S. and Koya, D. (2009) SIRT1 and insulin resistance. Nat. Rev. Endocrinol., 5, 367-373.
14. Rutanen, J., Yaluri, N., Modi, S., Pihlajamaki, J., Vanttinen, M., Itkonen, P., Kainulainen, S., Yamamoto, H., Lagouge, M., Sinclair, D. A. et al. (2010) SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes, 59, 829-835.
15. de Kreutzenberg, S. V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., Cobelli, C., Fadini, G. P. and Avogaro, A. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes, 59, 1006-1015.
16. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B. et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450, 712-716. (Pubitemid 350207685)
17. Hotamisligil, G. S. and Erbay, E. (2008) Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol., 8, 923-934.
18. Liu, J., Divoux, A., Sun, J., Zhang, J., Clement, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z. et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med., 15, 940-945.
19. Lee, H. J., Oh, Y. K., Rhee, M., Lim, J. Y., Hwang, J. Y., Park, Y. S., Kwon, Y., Choi, K. H., Jo, I., Park, S. I. et al. (2007) The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J. Mol. Biol., 369, 967-984. (Pubitemid 46754063)
20. McGillicuddy, F. C., Chiquoine, E. H., Hinkle, C. C., Kim, R. J., Shah, R., Roche, H. M., Smyth, E. M. and Reilly, M. P. (2009) Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem., 284, 31936-31944.
21. Kong, X., Fang, M., Li, P., Fang, F. and Xu, Y. (2009) HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. J. Mol. Cell. Cardiol., 46, 292-299.
22. Valenta, T., Lukas, J., Doubravska, L., Fafilek, B. and Korinek, V. (2006) HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies. EMBO J., 25, 2326-2337. (Pubitemid 44012216)
23. Okazaki, M., Iwasaki, Y., Nishiyama, M., Taguchi, T., Tsugita, M., Nakayama, S., Kambayashi, M., Hashimoto, K. and Terada, Y. (2010) PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr. J., 57, 403-413.
24. Franko, A., Mayer, S., Thiel, G., Mercy, L., Arnould, T., Hornig-Do, H. T., Wiesner, R. J. and Goffart, S. (2008) CREB-1alpha is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation. Mol. Cell. Biol., 28, 2446-2459. (Pubitemid 351429988)
25. Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P. et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature, 413, 179-183. (Pubitemid 32867880)
26. Gilde, A. J., van der Lee, K. A., Willemsen, P. H., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B. and van Bilsen, M. (2003) Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res., 92, 518-524. (Pubitemid 36368664)
27. Huss, J. M., Kopp, R. P. and Kelly, D. P. (2002) Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and-gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem., 277, 40265-40274. (Pubitemid 35215598)
28. Fang, M., Kong, X., Li, P., Fang, F., Wu, X., Bai, H., Qi, X., Chen, Q. and Xu, Y. (2009) RFXB and its splice variant RFXBSV mediate the antagonism between IFNgamma and TGFbeta on COL1A2 transcription in vascular smooth muscle cells. Nucleic Acids Res., 37, 4393-4406.
29. Xu, Y., Wang, L., Buttice, G., Sengupta, P. K. and Smith, B. D. (2004) Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma). J. Biol. Chem., 279, 41319-41332. (Pubitemid 39328146)
30. Xu, Y., Harton, J. A. and Smith, B. D. (2008) CIITA mediates interferon-gamma repression of collagen transcription through phosphorylation dependent interactions with co-repressor molecules. J. Biol. Chem., 283, 1243-1256.
31. Kong, X., Fang, M., Fang, F., Li, P. and Xu, Y. (2009) PPARgamma enhances IFNgamma-mediated transcription and rescues the TGFbeta antagonism by stimulating CIITA in vascular smooth muscle cells. J. Mol. Cell. Cardiol., 46, 748-757.
32. Van Rechem, C., Boulay, G., Pinte, S., Stankovic-Valentin, N., Guerardel, C. and Leprince, D. (2010) Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol. Cell Biol., 30, 4045-4059.
33. Zika, E., Greer, S. F., Zhu, X. S. and Ting, J. P. (2003) Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Mol. Cell. Biol., 23, 3091-3102. (Pubitemid 36459224)
34. Coppari, R., Ramadori, G. and Elmquist, J. K. (2009) The role of transcriptional regulators in central control of appetite and body weight. Nat. Clin. Pract. Endocrinol. Metab., 5, 160-166.
35. Wu, X., Kong, X., Luchsinger, L., Smith, B. D. and Xu, Y. (2009) Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities. Mol. Cell. Biol., 29, 5639-5644.
36. Ting, J. P. and Davis, B. K. (2005) CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol., 23, 387-414. (Pubitemid 40563175)
37. Schroder, K., Zhou, R. and Tschopp, J. (2011) The NLRP3 inflammasome: a sensor for metabolic dangeri Science, 327, 296-300.
38. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M. and Dixit, V. D. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med., 17, 179-188.
39. Fleuriel, C., Touka, M., Boulay, G., Guerardel, C., Rood, B. R. and Leprince, D. (2009) HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. Int. J. Biochem. Cell Biol., 41, 26-33.
40. Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W. and Baylin, S. B. (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell, 123, 437-448. (Pubitemid 41546674)
41. Deltour, S., Pinte, S., Guerardel, C., Wasylyk, B. and Leprince, D. (2002) The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell Biol., 22, 4890-4901. (Pubitemid 34620422)
42. Zhang, Q., Wang, S. Y., Fleuriel, C., Leprince, D., Rocheleau, J. V., Piston, D. W. and Goodman, R. H. (2007) Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl Acad. Sci. USA, 104, 829-833. (Pubitemid 46154696)
43. Jagannathan-Bogdan, M., McDonnell, M. E., Shin, H., Rehman, Q., Hasturk, H., Apovian, C. M. and Nikolajczyk, B. S. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol., 186, 1162-1172.
44. Zika, E. and Ting, J. P. (2005) Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol., 17, 58-64. (Pubitemid 40094015)
45. Jin, J., Iakova, P., Jiang, Y., Medrano, E. E. and Timchenko, N. A. (2011) The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology., 54, 989-998.
46. Li, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J. and Wong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J., 19, 4342-4350. (Pubitemid 30623745)
47. Alenghat, T., Meyers, K., Mullican, S. E., Leitner, K., Adeniji-Adele, A., Avila, J., Bucan, M., Ahima, R. S., Kaestner, K. H. and Lazar, M. A. (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature, 456, 997-1000.
48. McGee, S. L. and Hargreaves, M. (2010) Histone modifications and skeletal muscle metabolic gene expression. Clin. Exp. Pharmacol. Physiol., 37, 392-396.